GCM
TAK icon

Graham Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Graham Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,834
Closed -$232K – 1575
2025
Q3 		$232K Sell
15,834
-33,452
-68% -$497K ﹤0.01% 982
2025
Q2 		$762K Sell
49,286
-109,474
-69% -$1.62M 0.01% 672
2025
Q1 		$2.36M Buy
+158,760
New +$2.22M 0.04% 276
2023
Q4 		– Sell
-11,061
Closed -$171K – 1321
2023
Q3 		$171K Buy
+11,061
New +$171K ﹤0.01% 881

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Graham Capital Management's TAK Position: Q4 2025 in Review

Graham Capital Management sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 15,834 shares — an estimated $232K sold.

Graham Capital Management first reported a position in TAK in Q3 2023 and held it in 4 quarters. The position peaked at $2.36M in Q1 2025. 348 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Graham Capital Management reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 15,834 Takeda Pharmaceutical shares in Q4 2025, an estimated $232K.
  • Graham Capital Management first reported a position in Takeda Pharmaceutical in Q3 2023 and held it in 4 quarters.
  • Graham Capital Management's Takeda Pharmaceutical position peaked at $2.36M in Q1 2025.
  • 348 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.